Cost effective | Integrated – In Vivo, In Vitro, In Silico | Contract Service Lab
Lead compounds failing are a likelihood in any discovery effort. When a product is delayed in failure, it is a major hindrance with any sized development company for launching new medicines, and all the capital invested into the product up to that point is lost. At Drik, we believe the future of any drug discovery depends on its present safety testing: the earlier the failure, whether for lack of safety or efficacy, the earlier any expensive clinical trials can be avoided.
Our aim is to provide customized, cost-effective studies, which provide results within a short timespan. We let you focus on product progression while we simultaneously work on the safety, efficacy, and toxicology studies required as part of your development activity, and take your innovation to the clinical trial phase.
DRIK offers non-GLP and GLP testing in rodents, dogs, and monkeys. We have dealt with a wide and diverse range of compounds (such as small molecules and biologicals) and models and routes (such as oral and parenteral), and have successfully established programs that avoid the risk involved in product development.